Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
42.50
-2.00 (-4.49%)
At close: Jan 21, 2026
TPEX:7871 Market Cap
TPEX:7871 has a market cap or net worth of 5.71 billion as of January 21, 2026.
Market Cap
5.71B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
42.50
Market Cap Chart
Since January 13, 2026, TPEX:7871's market cap has increased from 5.30B to 5.71B, an increase of 7.59%. That is a compound annual growth rate of 2,721.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.71B | -4.49% |
| Jan 20, 2026 | 5.98B | -9.09% |
| Jan 19, 2026 | 6.57B | -3.45% |
| Jan 16, 2026 | 6.81B | 11.55% |
| Jan 15, 2026 | 6.10B | 0.78% |
| Jan 14, 2026 | 6.06B | 14.18% |
| Jan 13, 2026 | 5.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Power Technology | 6.09B |
| Delta Asia International | 6.08B |
| Hi-Clearance | 6.08B |
| MiTAC Digital Technology | 6.07B |
| Rich Development | 6.03B |
| Pacific Hospital Supply | 6.03B |
| Formosa Optical Technology | 5.99B |
| FineTek | 5.99B |